NCT01141296

Fenofibrate in Combination With Ursodeoxycholic Acid (UDCA) in Primary Biliary Cirrhosis

Randomized Controlled Study of Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis

• Status: Withdrawn
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: University of Miami · Academic / Other
• Sex: All
• Age: 21 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine if the combination of ursodeoxycholic acid (UDCA) and fenofibrate is more effective than UDCA alone in the treatment of primary biliary cirrhosis.

Conditions

• Primary Biliary Cirrhosis

Interventions

Type	Name	Description
DRUG	fenofibrate	fenofibrate 200 mg PO daily for 1 year
DRUG	placebo	Placebo pill identical to active drug will be given PO once a day for 1 year

Timeline

• Start date: 2011-04-01
• First posted: 2010-06-10
• Last updated: 2014-04-02

Locations

2 sites across 1 country: United States